NASDAQ: CHRS
Now that Coherus Oncology Inc’s volume has hit 1.28 million, investors get a glimpse of its size.
On Tuesday, Coherus Oncology Inc (NASDAQ: CHRS) opened higher 7.08% from the last session, before settling in for the closing ...
Coherus Oncology Inc (CHRS) last year’s performance of -8.70% is a clear signal for an entertaining trading season.
Coherus Oncology Inc (NASDAQ: CHRS) on Monday, plunged -5.97% from the previous trading day, before settling in for the closing ...
Coherus Oncology Inc (CHRS) latest performance of -4.79% is not what was on cards
Coherus Oncology Inc (NASDAQ: CHRS) flaunted slowness of -4.79% at $1.49, as the Stock market unbolted on thursday, before settling ...
Now that Coherus Oncology Inc’s volume has hit 1.76 million, investors get a glimpse of its size.
On Tuesday, Coherus Oncology Inc (NASDAQ: CHRS) was 8.75% up from the session before settling in for the closing price ...
Coherus Oncology Inc (CHRS) EPS is poised to hit -0.35 next quarter: How Investors Can Make It Count the Most?
Coherus Oncology Inc (NASDAQ: CHRS) started the day on Thursday, with a price increase of 3.41% at $1.82, before settling ...
Coherus Oncology Inc (CHRS) is set for another landmark as it hit the volume of 1.01 million
Coherus Oncology Inc (NASDAQ: CHRS) flaunted slowness of -1.22% at $1.62, as the Stock market unbolted on Wednesday, before settling ...
